Descripción del título
Endocrine secrets [[edited ...
The new, 5th Edition of Endocrine Secrets, by Michael McDermott, MD, continues the tradition of the highly popular Secrets Series®. A two-color page layout, question-and-answer approach, and chapter containing the "Top 100 Secrets? offer a quick and current overview of essential knowledge in endocrinology. Updates throughout equip you with cutting-edge coverage, while new contributors present the latest perspectives. A wealth of user-friendly features-including valuable pearls, tips, and memory aids-help you to learn more efficiently. It all adds up to the perfect concise board review or handy
Monografía
monografia Rebiun26137177 https://catalogo.rebiun.org/rebiun/record/Rebiun26137177 m o d | cr -n--------- 081208s2009 paua ob 001 0 eng 2008053212 0-323-07477-4 UPVA 997185054503706 CBUC 991005179577906711 CBUC 991004007953906713 CBUC 991003517156906714 CBUC 991013398582306708 CBUC 991000729606606712 CBUC 991010913910606709 MiAaPQ MiAaPQ MiAaPQ eng 616.40076 Endocrine secrets electronic resource] [edited by] Michael T. McDermott 5th ed Philadelphia, PA Mosby/Elsevier c2009 Philadelphia, PA Philadelphia, PA Mosby/Elsevier 1 online resource (590 p.) 1 online resource (590 p.) Text txt computer c online resource cr Secrets series Description based upon print version of record Includes bibliographical references and index Front Cover; Endocrine Secrets; Copyright Page; Dedication Page; Contents; Preface; Contributing Authors; Top 100 Secrets; I. Fuel Metabolism; Chapter 1: Diabetes Mellitus; 1. What is diabetes mellitus?; 2. What is the prevalence of diabetes?; 3. Is screening for type 1 diabetes recommended?; 4. Who should be screened for type 2 diabetes?; 5. How is diabetes diagnosed?; 6. What are the genetics of type 1 diabetes?; 7. What are the genetics of type 2 diabetes?; 8. Describe the pathogenesis of type 1 diabetes; 9. Describe the pathogenesis of type 2 diabetes; 10. Can diabetes be prevented? 11. What techniques are available to assess insulin resistance?12. Describe metabolic syndrome; 13. What causes beta-cell failure in type 2 diabetes?; 14. What are the standards of care for management of diabetes mellitus?; 15. Describe the current management approach to type 1 diabetes and the role of intensive therapy modeled by the Diabetes Control andComplications Trial (DCCT); 16. Is intensive diabetes therapy cost-effective?; 17. What is the United Kingdom Prospective Diabetes Study (UKPDS)?; 18. What is the current management approach with type 2 diabetes? 19. Based on the UKPDS and other studies, describe the optimal treatment for type 2 diabetes20. What are insulin analogs?; 21. What is inhaled insulin?; 22. What is amylin?; 23. What are incretins?; 24. How are incretins used to treat type 2 diabetes?; 25. What are the classes of oral diabetes medications? How do they work?; Bibliography; Chapter 2: Acute and Chronic Complications of Diabetes; 1. What are the acute complications of diabetes?; 2. Describe the symptoms of hyperglycemia; 3. What is DKA?; 4. What causes DKA?; 5. What illnesses may trigger DKA? 6. How can deficiencies in education trigger DKA?7. What are the signs and symptoms of DKA?; 8. How is DKA diagnosed?; 9. Is ketone testing always positive with DKA?; 10. What lab tests are recommended in the first hour of treatment for DKA?; 11. Summarize the strategy for fluid and potassium administration in the first hour; 12. How should insulin treatment be started with DKA?; 13. What assessments should be made in the second hour of treatment?; 14. Summarize the strategy for fluid and potassium administration in the second hour of treatment 15. How should insulin be adjusted during treatment?16. Summarize the basic strategy after the second hour of treatment; 17. When can the insulin infusion be discontinued?; 18. What other interventions may be necessary in the treatment of DKA?; 19. What is a possible complication of DKA? How should it be treated?; 20. What is hyperosmolar hyperglycemic syndrome?; 21. Who is at risk for HHS and why?; 22. What are the signs of HHS?; 23. Why is metabolic acidosis typically not seen in HHS?; 24. What are the symptoms of HHS?; 25. What is the most common presenting symptom of HHS? 26. List other possible causes of impaired mental status The new, 5th Edition of Endocrine Secrets, by Michael McDermott, MD, continues the tradition of the highly popular Secrets Series®. A two-color page layout, question-and-answer approach, and chapter containing the "Top 100 Secrets? offer a quick and current overview of essential knowledge in endocrinology. Updates throughout equip you with cutting-edge coverage, while new contributors present the latest perspectives. A wealth of user-friendly features-including valuable pearls, tips, and memory aids-help you to learn more efficiently. It all adds up to the perfect concise board review or handy English Endocrinology- Examinations, questions, etc. Endocrine glands- Diseases- Examinations, questions, etc. Electronic books McDermott, Michael T. 1952-) 0-323-05885-X Secrets series